The U.K. won a pledge from Pfizer Inc. (NYSE:PFE) to protect research jobs in the country should it succeed in buying AstraZeneca Plc. (AZN) Sweden, the home country of AstraZeneca Chairman Leif Johansson, has received no such assurances. Pfizer Inc. (NYSE:PFE) shares after opening at $30.00 moved to $30.01 on last trade day and at the end of the day closed at $29.43. Company price to sales ratio in past twelve months was calculated as 3.64 and price to cash ratio as 5.79. Pfizer Inc. (NYSE:PFE) showed a negative weekly performance of -7.34%.
Merck & Co Inc. (NYSE:MRK) has agreed to sell its consumer care business to Germany’s Bayer AG for $14.2 billion, the companies said on Tuesday, adding to a string of major cross-border healthcare deals. Merck said it expects after-tax proceeds of between $8 billion and $9 billion from the sale, which is expected to close in the second half of 2014. Merck & Co., Inc. (NYSE:MRK) shares fell -2.59% in last trading session and ended the day on $57.11. MRK return on equity ratio is recorded as 12.40% and its return on assets is 5.70%. Merck & Co., Inc. (NYSE:MRK) yearly performance is 31.47%.
Bristol-Myers Squibb Company (NYSE:BMY) yesterday announced that Brian Daniels, senior vice president, Global Development and Medical Affairs, will be retiring from the company, effective July 1, 2014. Bristol-Myers Squibb Co (NYSE:BMY) shares moved up 1.80% in last trading session and was closed at $50.93, while trading in range of $49.72 – $51.24. Bristol-Myers Squibb Co (NYSE:BMY) year to date (YTD) performance is -3.51%.
On April 24, 2014, Johnson & Johnson (NYSE:JNJ) Board of Directors declared a regular cash dividend of $0.70 per share, payable on June 10, 2014 to shareholders of record as of May 27, 2014. Johnson & Johnson (NYSE:JNJ) weekly performance is -1.50%. On last trading day company shares ended up $99.51. Johnson & Johnson (NYSE:JNJ) distance from 50-day simple moving average (SMA50) is 3.23%. Analysts mean target price for the company is $104.55.
Leave a Reply